MabCure Shares Outstanding vs. Cash And Equivalents
| MBCI Stock | USD 0.0001 0.00 0.00% |
For MabCure profitability analysis, we use financial ratios and fundamental drivers that measure the ability of MabCure to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well MabCure utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between MabCure's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of MabCure over time as well as its relative position and ranking within its peers.
MabCure |
MabCure Cash And Equivalents vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining MabCure's current stock value. Our valuation model uses many indicators to compare MabCure value to that of its competitors to determine the firm's financial worth. MabCure is regarded fifth in shares outstanding category among its peers. It also is regarded fifth in cash and equivalents category among its peers . The ratio of Shares Outstanding to Cash And Equivalents for MabCure is about 439.52 . Comparative valuation analysis is a catch-all model that can be used if you cannot value MabCure by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for MabCure's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.MabCure Cash And Equivalents vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
MabCure |
| = | 64.36 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
MabCure |
| = | 146.44 K |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
MabCure Cash And Equivalents Comparison
MabCure is currently under evaluation in cash and equivalents category among its peers.
MabCure Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in MabCure, profitability is also one of the essential criteria for including it into their portfolios because, without profit, MabCure will eventually generate negative long term returns. The profitability progress is the general direction of MabCure's change in net profit over the period of time. It can combine multiple indicators of MabCure, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. MabCure Inc. was founded in 2006 and is based in White Plains, New York. Mabcure is traded on OTC Exchange in the United States.
MabCure Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on MabCure. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of MabCure position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the MabCure's important profitability drivers and their relationship over time.
Use MabCure in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if MabCure position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MabCure will appreciate offsetting losses from the drop in the long position's value.MabCure Pair Trading
MabCure Pair Trading Analysis
The ability to find closely correlated positions to MabCure could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace MabCure when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back MabCure - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling MabCure to buy it.
The correlation of MabCure is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as MabCure moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if MabCure moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for MabCure can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your MabCure position
In addition to having MabCure in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Copper Thematic Idea Now
Copper
Companies involved in production of copper. The Copper theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Copper Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in MabCure Pink Sheet
To fully project MabCure's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of MabCure at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include MabCure's income statement, its balance sheet, and the statement of cash flows.